Meridian Bioscience (VIVO) Tops Q2 EPS by 8c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 2.60 -0.22 (7.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $21.49 | |||
| Open | $2.75 | 52 Week Low | $15.75 | |||
| Day High | $2.75 | P/E | 2.95 | |||
| Day Low | $2.51 | EPS | $0.88 | |||
| Volume | 406,547 | |||||
